In Brief
Sumaria et al. identify distinct thymic pathways that generate murine gd T cells pre-committed to the secretion of IL-17A or IFNg. This permits assessment of TCRgd signal strength in thymic commitment to gd T cell effector fate; increased TCRgd signal strength profoundly prohibits development of all IL-17A-secreting gd T cells.
INTRODUCTION
gd T cells make rapid non-redundant contributions in numerous disease settings that include malaria (Behr et al., 1996) and tuberculosis infections (Kabelitz et al., 1991) , as well as immunopathologies such as psoriasis (Laggner et al., 2011) . In addition, gd T cells display potent anti-tumor capabilities, such that a tumor-associated gd T cell expression signature was the most favorable immune-related positive prognostic indicator in analyses of more than 18,000 tumors (Gentles et al., 2015) .
Murine gd T cells execute their effector capacities through provision of cytokines . Anti-tumor function is associated with IFNg production (Gao et al., 2003) , whereas IL-17A drives gd T cell responses to extracellular bacteria and fungi (Dejima et al., 2011; Hamada et al., 2008) . This delivery of IFNg or IL-17A mirrors that of ab T helper cell clones that acquire cytokine-secreting functions only at the point of peripheral activation in secondary lymphoid tissue. By contrast, gd T cells largely acquire their effector potential (to secrete IFNg or IL-17A) in the thymus, well before their participation in subsequent immune responses (Ribot et al., 2009 ).
The mechanisms that drive thymic commitment to gd T cell effector function are still unclear. ''Strong'' ligand-dependent signaling through the gd T cell receptor (TCRgd) was suggested to promote commitment to an IFNg-secreting fate (Jensen et al., 2008; Muñ oz-Ruiz et al., 2016; Turchinovich and Hayday, 2011) , with weaker, possibly ligand-independent TCR signaling being required for IL-17A production (Jensen et al., 2008; Turchinovich and Hayday, 2011) . However, recent studies have also implicated ''strong'' TCRgd signals in commitment to an IL-17A-secreting fate (Coffey et al., 2014; Wencker et al., 2014) . Alternatively, evidence exists for TCR-independent commitment to effector potentials. For example, IL-17A-secreting gd T cells develop exclusively in a perinatal window, such that adoptive transfer of adult bone marrow will not reconstitute the IL-17A-secreting gd T cell compartment (Haas et al., 2012) . IL-17A-producing gd T cells are also suggested to preferentially develop from CD4
À

CD8
À double-negative (DN) 2 cells (rather than DN3 cells) (Shibata et al., 2014) . And certain gd T cell subsets (e.g., those using a TCRg chain incorporating variable region 4; Vg4 + cells) may inherently require certain transcription factors (e.g., Sox-13) (Gray et al., 2013; Malhotra et al., 2013) . Clearly, a better understanding of gd T cell development is required that will provide critical insight into gd T cell biology. There is presently no accepted approach for stage-wise assessment of thymic gd T cell development. Indeed, although studies have analyzed Vg usage (Gray et al., 2013; Turchinovich and Hayday, 2011) , acquisition of effector potential (Jensen et al., 2008; Lombes et al., 2015; Ribot et al., 2009; Turchinovich and Hayday, 2011) , gene transcription (Schmolka et al., 2013) , and surface marker expression (Coffey et al., 2014; Haas et al., 2009; Jensen et al., 2008; Lombes et al., 2015; Ribot et al., 2009; Turchinovich and Hayday, 2011) , a methodology that combines these parameters, akin to that for ab T cells, is still lacking. Here, using precursor/product relationships, we identify thymic stages in two distinct developmental pathways that generate gd T cells committed to subsequent secretion of IL-17A or IFNg. This exposes a temporal disconnect between thymic commitment to effector fate and immediate capacity to display effector function. Cytokine-independent identification of fate-committed gd T cells reveals the full contribution of Vg-chain-expressing progenitors to both cytokine-producing pathways through ontogeny, highlighting sizable numbers of IL-17A-committed cells expressing Vg1 and Vg2/3 chains. Importantly, these analyses also permit definitive assessment of TCRgd signal strength in commitment to gd T cell effector fate; increased TCRgd signal strength profoundly prohibits the development of all IL-17A-secreting gd T cells, regardless of Vg usage but promoted the development of gd progenitors along the IFNg pathway. These observations provide important insights into functional gd T cell biology.
RESULTS
CD24, CD44, and CD45RB Identify Functionally Distinct gd T Cell Subsets
There is no consensus for describing stages in murine gd T cell development. Thus, we re-assessed, on perinatal, neonatal, and post-natal thymic gd T cells, the expression of gd T cell surface markers (Coffey et al., 2014; Haas et al., 2009; Jensen et al., 2008; Ribot et al., 2009; Wencker et al., 2014) combined with intracellular (i.c.) staining for IFNg and IL-17A ( Figure S1 ). This revealed that staining for CD24, CD44, and CD45RB neatly segregated both thymic ( Figure 1A ) and peripheral ( Figure 1B ) gd T cells, throughout ontogeny ( Figure S2A ), into two apparent ''pathways''; CD24 À cells that expressed high CD44 but not CD45RB were committed to IL-17A secretion, but did not make IFNg, whereas cells that had upregulated CD45RB had potential to secrete IFNg but not IL-17A ( Figures 1A and 1B ).
CD45RB
hi gd T cells can also upregulate CD44, which correlates with NK1.1 and CD122 expression and robust peripheral commitment to IFNg secretion ( Figure 1C ). Consistent with IL-17A-secreting potential (Michel et al., 2012; Ribot et al., 2009; Schmolka et al., 2013) Figures 1D and S2B ) and expressed significant CD127 (the IL-7Ra chain) that appeared to follow upregulation of CD44 ( Figure 1E ). By contrast, CD44 + CD45RB
+ gd cells were T-bet + RORgt lo and displayed little CD127 ( Figures 1D,  1E , and S2B). Finally, although we could not detect IL-4-secreting gd T cells directly ex vivo, a small fraction of the CD44 + CD45RB + subset from both post-natal thymus and adult spleen produced IL-4 after 18 hr culture in PMA/ionomycin ( Figure S2C ). Thus, in the thymus and periphery, CD24, CD44, and CD45RB neatly segregate gd T cells into subsets with IL-17A-or IFNg-secreting potential. T cells or CD45RB + IFNg-committed gd T cells. To formally investigate this hypothesis, we used fetal thymic organ culture (FTOC) that re-capitulates thymic T cell development in vitro and is suited to studying gd T cell development that occurs predominantly in the perinatal period. Indeed, E15 thymic lobes cultured for 7 days generate gd T cell subsets similar to those observed ex vivo ( Figure 2A ). To show precursor/product relationships, we first took E14 lobes and cultured them in FTOC for either 1 or 2 days. Ex vivo, gd T cells from E14 lobes are all CD24 + , with a sizable proportion also CD25 + ( Figure 2B ). Consistent with CD25 + gd T cells' being the earliest gd T cell subset in the thymus (Prinz et al., 2006; Ribot et al., 2009) , the proportion of these cells is notably reduced over a 2-day culture period. On day 1, CD24 + CD25 À cells were the dominate subset, whereas by day 2, a substantial proportion of cells became CD24 (Prinz et al., 2013) . However, this is difficult to study in the early thymus, as only a minority of neonatal CD24 À gd T cells display immediate cytokine-secreting capacity after 4 hr stimulation with PMA/ ionomycin ( Figure S3A ). In contrast, the vast majority of these CD24 À cells have already entered one of the two developmental pathways described above ( Figure 1A ) and are thus already committed to a cytokine-secreting fate ( Figure 2C ). To use this extra sensitivity to observe cytokine-committed TCRgd + thymo- Figure 3B ), which corresponded to T-bet (but not RORgt) expression in Vg5 + cells and RORgt (but not T-bet) expression in Vg6 + cells ( Figure 3C Figure 3D ). Finally, Vg7 + cells, which are readily identifiable in early CD24 + subsets, are barely 
Increased TCRgd Signal Strength Restricts Development of All IL-17A-Secreting gd T Cells
The factors that dictate commitment to an IL-17A-or IFNgsecreting fate are still unclear. Central to this is the role of TCRgd signaling, as although consensus suggests that ''strong'' TCRgd signals favor development of IFNg-committed cells (Jensen et al., 2008; Muñ oz-Ruiz et al., 2016; Turchinovich and Hayday, 2011) , conflicting views exist as to the strength of TCRgd signal required for an IL-17A-secreting fate (Coffey et al., 2014; Jensen et al., 2008; Turchinovich and Hayday, 2011; Wencker et al., 2014) . In 7-day FTOC of E15 thymic lobes, addition of antiTCRgd antibody GL3, which increases TCRgd signal strength (Kreslavsky et al., 2008; Turchinovich and Hayday, 2011) , clearly reduced the generation of IL-17A-committed cells while significantly increasing the number of CD44 + CD45RB + cells ( Figures   4A and 4B ). The effect on those cells capable of immediate IL-17A secretion was particularly dramatic, reducing both absolute cell number and the amount of IL-17A produced per cell (Figure 4C ). This effect was GL3 dose dependent ( Figure S4A ), was not the result of TCR signaling-induced apoptosis (Figure S4B) , and resulted in a complete absence of all Vg-expressing cells in the IL-17A pathway if GL3 was added to 7-to 14-day FTOC of E14 thymic lobes ( Figure S4C ). Moreover, intraperitoneal administration to pregnant wild-type (WT) mice at 13-days post-conception of the anti-CD3ε antibody 2C11, which induces similar developmental changes as GL3 in vitro ( Figure S4D ), also resulted in profound reduction of IL-17A-commited gd T cells in pups at day 2 after birth ( Figure 4D ). Finally, and consistent with these findings, cells from the IFNg pathway, from either 7-day FTOC or day 2 pups ex vivo, displayed significantly more CD73 (a marker linked to [strong] TCRgd-ligand-induced signaling; Coffey et al., 2014) , than cells from the IL-17A pathway, regardless of Vg usage ( Figure 4E ). TCR signals are transduced, in part, by signals through the ERK/MAP kinase cascade (Haks et al., 2005) . Hence, to assess the consequences of weaker TCRgd signaling, the MEK1/2 inhibitor of ERK signaling UO126 was added to 7-day E15 FTOC. Compared with control cultures, UO126 significantly increased cell number in the IL-17A-committed pathway (Figures 4F and 4G ) while reducing the ratio of terminally differentiated CD44 + CD45RB + cells to less mature CD44 À CD45RB + cells in the IFNg-committed pathway ( Figure 4H ). Importantly, UO126 could also rescue the number of IL-17A-committed cells in FTOC containing GL3 (Figures 4F and 4G ) and improved the ratio of CD44 + CD45RB
+ to CD44 À CD45RB + cells ( Figure 4H ). Thus, manipulation of TCRgd signal strength with either crosslinking anti-TCRgd antibody (stronger) or an ERK pathway inhibitor (weaker) demonstrates that strong TCRgd signals are prohibitive for the generation of gd T cells destined to secrete IL-17A, regardless of the Vg chain they use.
DISCUSSION
Here, we describe a straightforward methodology to study the sequential thymic development of murine gd T cells. TCRd + CD25 + cells, which are considered the earliest thymic gd T cell subset (Prinz et al., 2006; Ribot et al., 2009) , begin development by downregulating CD25, followed by CD24. How this is triggered remains to be elucidated, but TCRgd signaling was shown to be necessary to pass beyond a TCRgd lo CD25 + stage (Prinz et al., 2006) . When cultured as a population, CD24 À gd thymocytes that are CD44 À CD45RB À give rise to either IL-17A-committed CD44 hi CD45RB À cells that express RORgt but not T-bet or to IFNg-committed CD45RB + cells that (more gradually) express T-bet but not RORgt. Interestingly, our CD44/ CD45RB plots show overlap with CD44/Ly-6C plots suggested to identify naive-like and memory-like peripheral gd T cell subsets (Lombes et al., 2015) . Thus, combination staining of CD44 with both Ly-6C and CD45RB may prove particularly insightful. Importantly, our analyses identify two thymic pathways of functional gd T cell differentiation that diverge from a common CD24 À CD44 The identification of surface marker-defined, cytokine secretion-independent developmental pathways for gd T cell generation facilitated re-examination of TCRgd signal strength requirements for thymic commitment of gd progenitors to specific effector fates. Strong antibody-induced TCRgd signaling favored the IFNg pathway (Jensen et al., 2008; Muñ oz-Ruiz et al., 2016; Ribot et al., 2009; Turchinovich and Hayday, 2011) . This was consistent with significantly higher expression of CD73 (recently purported to reflect increased TCRgd signaling; Coffey et al., 2014) Mice C57BL/6 (B6) mice were purchased from Charles River Laboratories. All mice were fetal (E14-E17), neonatal (1-3 days), post-natal (4-8 days), or adult (8-12 weeks; female). All experiments involving animals were performed in full compliance with UK Home Office regulations and institutional guidelines.
FTOCs
Thymic lobes from B6 mice were cultured on Nuclepore membrane filter discs (Whatman) in complete RPMI-1640 medium plus 10% fetal calf serum (FCS) for 7-14 days.
OP9-DL1 Co-cultures OP9-DL1 cells were provided by J.C. Zú niga-Pfl€ ucker (University of Toronto).
Flow Cytometry
For detection of Vg5Vd1 and Vg6Vd1, cells were pre-stained with GL3 followed by 17D1. For i.c. cytokine staining (eBioscience), cells were stimulated with 50 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma) and 1 mg/ml ionomycin (Sigma) for 4 hr at 37 C. Acquisition was performed with an LSR-II or a Canto II (BD). Analysis was performed using FlowJo (Tree Star).
Statistical Analysis
GraphPad Prism software was used to analyze data, which are presented as mean ± SD. Two-tailed Student's unpaired t test was used when only two groups were compared, and one-way ANOVA with Tukey's test was used for multiple comparisons. Significance was determined at p % 0.05. 
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